Literature DB >> 10562493

Frequency of CD8(+) T lymphocytes specific for lytic and latent antigens of Epstein-Barr virus in healthy virus carriers.

G Benninger-Döring1, S Pepperl, L Deml, S Modrow, H Wolf, W Jilg.   

Abstract

We investigated CD8(+) T cell frequencies of five different Epstein-Barr virus-specific cytotoxic T lymphocyte epitopes located within proteins of the replicative cycle and the latent state in healthy long-term virus carriers with IFN-gamma enzyme-linked immunospot assay. Frequencies of the HLA-A3-restricted epitope RVRAYTYSK (RVR) whose minimal length was mapped in this study to amino acid position 148-156 of the immediate-early protein BRLF1 were compared with those of a further known HLA-A3-restricted epitope within EBNA3A, RLRAEAQVK (RLR). Determination of frequencies of CD8(+) T lymphocytes directed against lytic antigen epitope RVR revealed that only one of eight donors recognized this epitope. Frequency was calculated to be 65 RVR-specific CD8(+) T lymphocytes per 10(6) PBMC. None of the HLA-A3-positive donors exhibited IFN-gamma release after antigenic stimulation with the EBNA3A-specific peptide epitope RLR. Furthermore, we chose three known HLA-B8-restricted epitopes, RAKFKQLL (RAK), FLRGRAYGL (FLR), and QAKWRLQTL (QAK), of the lytic protein BZLF1 and the latent protein EBNA3A. Examination of eight HLA-B8-positive virus carriers revealed that the BZLF1-specific epitope RAK was recognized by all donors with a median frequency of 233 RAK-specific CD8(+) T lymphocytes per 10(6) PBMC. Only 50% of these donors reacted against EBNA3A-specific epitope FLR and a minority (25%) reacted against EBNA3A-specific epitope QAK. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562493     DOI: 10.1006/viro.1999.9996

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

Review 1.  Molecular virology of Epstein-Barr virus.

Authors:  G W Bornkamm; W Hammerschmidt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

2.  Age-associated Epstein-Barr virus-specific T cell responses in seropositive healthy adults.

Authors:  D Cárdenas Sierra; G Vélez Colmenares; A Orfao de Matos; S Fiorentino Gómez; S M Quijano Gómez
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

3.  A disease progression prediction model and nervous system symptoms in coronavirus disease 2019 patients.

Authors:  Yu Zhao; Fuxiang Wang; Gaolei Dong; Qi Sheng; Shiyan Feng
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

4.  Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection.

Authors:  Andrew D Hislop; Nicola E Annels; Nancy H Gudgeon; Alison M Leese; Alan B Rickinson
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

5.  Cross-Reactivity of Virus-Specific CD8+ T Cells Against Allogeneic HLA-C: Possible Implications for Pregnancy Outcome.

Authors:  Anita van der Zwan; Ellen M W van der Meer-Prins; Paula P M C van Miert; Heleen van den Heuvel; Jacqueline D H Anholts; Dave L Roelen; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2018-12-06       Impact factor: 7.561

6.  Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease.

Authors:  David M Burns; Gordon B Ryan; Caroline M Harvey; Eszter Nagy; Simon Hughes; Paul G Murray; Nigel H Russell; Christopher P Fox; Heather M Long
Journal:  Front Immunol       Date:  2019-10-29       Impact factor: 7.561

7.  MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.

Authors:  Heather M Long; Odette L Chagoury; Alison M Leese; Gordon B Ryan; Eddie James; Laura T Morton; Rachel J M Abbott; Shereen Sabbah; William Kwok; Alan B Rickinson
Journal:  J Exp Med       Date:  2013-04-08       Impact factor: 14.307

8.  Long-lived memory T lymphocyte responses after hantavirus infection.

Authors:  Heather L Van Epps; Masanori Terajima; Jukka Mustonen; T Petteri Arstila; Elizabeth A Corey; Antti Vaheri; Francis A Ennis
Journal:  J Exp Med       Date:  2002-09-02       Impact factor: 14.307

9.  Application of the pMHC Array to Characterise Tumour Antigen Specific T Cell Populations in Leukaemia Patients at Disease Diagnosis.

Authors:  Suzanne E Brooks; Stephanie A Bonney; Cindy Lee; Amy Publicover; Ghazala Khan; Evelien L Smits; Dagmar Sigurdardottir; Matthew Arno; Demin Li; Ken I Mills; Karen Pulford; Alison H Banham; Viggo van Tendeloo; Ghulam J Mufti; Hans-Georg Rammensee; Tim J Elliott; Kim H Orchard; Barbara-ann Guinn
Journal:  PLoS One       Date:  2015-10-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.